Cell ther­a­py start­up rais­es $16 mil­lion to fund its quest for the Holy Grail in re­gen­er­a­tive med­i­cine

In 2006, Shinya Ya­mana­ka shook stem cell re­search with his dis­cov­ery that ma­ture cells can be con­vert­ed in­to stem cells, re­liev­ing a long­stand­ing po­lit­i­cal-eth­i­cal block­age …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER